My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cognition Therapeutics, Inc. - Common Stock (NQ:CGTX)

1.120 +0.050 (+4.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cognition Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today? ↗

July 29, 2024

NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.

Via InvestorPlace

Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today? ↗

July 29, 2024

Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.

Via InvestorPlace

Nasdaq Gains 1%; McDonald's Posts Downbeat Results ↗

July 29, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 29, 2024

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!

Via InvestorPlace

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2024

Via Benzinga

A Preview Of Cognition Therapeutics's Earnings ↗

March 25, 2024

Via Benzinga

Cognition Therapeutics's Earnings Outlook ↗

August 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 22, 2024

Via Benzinga

CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024 ↗

May 07, 2024

CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 22, 2024

Via Benzinga

CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q4 2023 ↗

March 26, 2024

CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying ↗

March 15, 2024

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Topics Stocks

Earnings Scheduled For March 26, 2024 ↗

March 26, 2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 04, 2024

Via Benzinga

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 17, 2024

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 27, 2023

Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...

Via Benzinga

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 26, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 26, 2023

Via Benzinga

Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

October 26, 2023

Gainers Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding...

Via Benzinga

Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

October 25, 2023

Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million...

Via Benzinga

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

Cognition Therapeutics – Could This Company's Technology Make Debilitating Neural Diseases Like Dementia A Thing Of The Past? ↗

July 06, 2023

Cognition Therapeutics, Inc. (NASDAQ: CGTX) is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic...

Via Benzinga

Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations ↗

June 28, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.